C Tamer Erel, Ipek Betul Ozcivit Erkan, Neslihan Gokmen, Marco Gambacciani, Adrian Gaspar, Leticia Lazzaletta, Nobuo Okui, Olga Pustotina, Levent M Senturk, Inci Sema Tas, Funda Gungor Ugurlucan, Cenk Yasa, Mert Urfalioglu
{"title":"经尿道和阴道内联合er: YAG激光（UEL + VEL）治疗与单纯经尿道（UEL）治疗压力性尿失禁？一项多中心回顾性队列研究，来自VELA中心的真实世界数据。","authors":"C Tamer Erel, Ipek Betul Ozcivit Erkan, Neslihan Gokmen, Marco Gambacciani, Adrian Gaspar, Leticia Lazzaletta, Nobuo Okui, Olga Pustotina, Levent M Senturk, Inci Sema Tas, Funda Gungor Ugurlucan, Cenk Yasa, Mert Urfalioglu","doi":"10.1007/s10103-025-04691-6","DOIUrl":null,"url":null,"abstract":"<p><p>This study aimed to compare the efficacy of the combined intraurethral and intravaginal (UEL + VEL) non-ablative Erbium (Er): YAG laser with UEL alone in improving the symptoms of stress urinary incontinence (SUI) and/or stress-dominant mixed urinary incontinence (MUI) in women.This retrospective, multicenter cohort study included 228 women with SUI and/or MUI, with 161 women in the UEL + VEL group and 67 in the UEL group. The primary outcome was the change International Consultation on Incontinence Questionnaire - Urinary Incontinence Short Form (ICIQ-UI SF) scores at baseline and at 3, 6, and 12 months.Demographic characteristics, including age, body mass index (BMI), and menopausal duration, were similar between the groups, with the exception of parity, which was significantly higher in the UEL group (2.49 ± 1.15 vs. 2.01 ± 1.15, p = 0.025). Baseline ICIQ-UI SF scores were significantly higher in the UEL + VEL group (12.08 ± 4.17 vs. 10.35 ± 4.95, p = 0.008). Over time, the UEL + VEL group showed a steeper and more substantial decline in symptom scores, eventually converging with the UEL group at 12 months. The UEL group, starting with lower baseline scores, showed a more moderate decline. This suggests that UEL + VEL might be more effective in reducing symptoms over time. Within-subjects test indicated that parity significantly influenced symptom improvement over time (p < 0.001, F = 13.843), and between-subjects test at 12 months showed that treatment type (p = 0.036, F = 4.479), parity (p = 0.002, F = 10.029), and their interaction (p = 0.022, F = 5.333). were significant predictors of outcome.Both UEL and combined UEL + VEL applications significantly improved UI symptoms up to 12 months. However, UEL + VEL was more effective overall. Parity was a significant factor influencing the treatment outcome, suggesting that increasing parity may be a prognostic factor in laser therapy for UI.</p>","PeriodicalId":17978,"journal":{"name":"Lasers in Medical Science","volume":"40 1","pages":"412"},"PeriodicalIF":2.4000,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Combined intraurethral and intravaginal er: YAG laser (UEL + VEL) therapy vs. intraurethral (UEL) alone treatment for stress urinary incontinence? a multicenter retrospective cohort study, real world data from the VELA centers.\",\"authors\":\"C Tamer Erel, Ipek Betul Ozcivit Erkan, Neslihan Gokmen, Marco Gambacciani, Adrian Gaspar, Leticia Lazzaletta, Nobuo Okui, Olga Pustotina, Levent M Senturk, Inci Sema Tas, Funda Gungor Ugurlucan, Cenk Yasa, Mert Urfalioglu\",\"doi\":\"10.1007/s10103-025-04691-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This study aimed to compare the efficacy of the combined intraurethral and intravaginal (UEL + VEL) non-ablative Erbium (Er): YAG laser with UEL alone in improving the symptoms of stress urinary incontinence (SUI) and/or stress-dominant mixed urinary incontinence (MUI) in women.This retrospective, multicenter cohort study included 228 women with SUI and/or MUI, with 161 women in the UEL + VEL group and 67 in the UEL group. The primary outcome was the change International Consultation on Incontinence Questionnaire - Urinary Incontinence Short Form (ICIQ-UI SF) scores at baseline and at 3, 6, and 12 months.Demographic characteristics, including age, body mass index (BMI), and menopausal duration, were similar between the groups, with the exception of parity, which was significantly higher in the UEL group (2.49 ± 1.15 vs. 2.01 ± 1.15, p = 0.025). Baseline ICIQ-UI SF scores were significantly higher in the UEL + VEL group (12.08 ± 4.17 vs. 10.35 ± 4.95, p = 0.008). Over time, the UEL + VEL group showed a steeper and more substantial decline in symptom scores, eventually converging with the UEL group at 12 months. The UEL group, starting with lower baseline scores, showed a more moderate decline. This suggests that UEL + VEL might be more effective in reducing symptoms over time. Within-subjects test indicated that parity significantly influenced symptom improvement over time (p < 0.001, F = 13.843), and between-subjects test at 12 months showed that treatment type (p = 0.036, F = 4.479), parity (p = 0.002, F = 10.029), and their interaction (p = 0.022, F = 5.333). were significant predictors of outcome.Both UEL and combined UEL + VEL applications significantly improved UI symptoms up to 12 months. However, UEL + VEL was more effective overall. Parity was a significant factor influencing the treatment outcome, suggesting that increasing parity may be a prognostic factor in laser therapy for UI.</p>\",\"PeriodicalId\":17978,\"journal\":{\"name\":\"Lasers in Medical Science\",\"volume\":\"40 1\",\"pages\":\"412\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2025-10-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Lasers in Medical Science\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.1007/s10103-025-04691-6\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lasers in Medical Science","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1007/s10103-025-04691-6","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
Combined intraurethral and intravaginal er: YAG laser (UEL + VEL) therapy vs. intraurethral (UEL) alone treatment for stress urinary incontinence? a multicenter retrospective cohort study, real world data from the VELA centers.
This study aimed to compare the efficacy of the combined intraurethral and intravaginal (UEL + VEL) non-ablative Erbium (Er): YAG laser with UEL alone in improving the symptoms of stress urinary incontinence (SUI) and/or stress-dominant mixed urinary incontinence (MUI) in women.This retrospective, multicenter cohort study included 228 women with SUI and/or MUI, with 161 women in the UEL + VEL group and 67 in the UEL group. The primary outcome was the change International Consultation on Incontinence Questionnaire - Urinary Incontinence Short Form (ICIQ-UI SF) scores at baseline and at 3, 6, and 12 months.Demographic characteristics, including age, body mass index (BMI), and menopausal duration, were similar between the groups, with the exception of parity, which was significantly higher in the UEL group (2.49 ± 1.15 vs. 2.01 ± 1.15, p = 0.025). Baseline ICIQ-UI SF scores were significantly higher in the UEL + VEL group (12.08 ± 4.17 vs. 10.35 ± 4.95, p = 0.008). Over time, the UEL + VEL group showed a steeper and more substantial decline in symptom scores, eventually converging with the UEL group at 12 months. The UEL group, starting with lower baseline scores, showed a more moderate decline. This suggests that UEL + VEL might be more effective in reducing symptoms over time. Within-subjects test indicated that parity significantly influenced symptom improvement over time (p < 0.001, F = 13.843), and between-subjects test at 12 months showed that treatment type (p = 0.036, F = 4.479), parity (p = 0.002, F = 10.029), and their interaction (p = 0.022, F = 5.333). were significant predictors of outcome.Both UEL and combined UEL + VEL applications significantly improved UI symptoms up to 12 months. However, UEL + VEL was more effective overall. Parity was a significant factor influencing the treatment outcome, suggesting that increasing parity may be a prognostic factor in laser therapy for UI.
期刊介绍：
Lasers in Medical Science (LIMS) has established itself as the leading international journal in the rapidly expanding field of medical and dental applications of lasers and light. It provides a forum for the publication of papers on the technical, experimental, and clinical aspects of the use of medical lasers, including lasers in surgery, endoscopy, angioplasty, hyperthermia of tumors, and photodynamic therapy. In addition to medical laser applications, LIMS presents high-quality manuscripts on a wide range of dental topics, including aesthetic dentistry, endodontics, orthodontics, and prosthodontics.
The journal publishes articles on the medical and dental applications of novel laser technologies, light delivery systems, sensors to monitor laser effects, basic laser-tissue interactions, and the modeling of laser-tissue interactions. Beyond laser applications, LIMS features articles relating to the use of non-laser light-tissue interactions.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
